Zhang X, Kelly S M, Bollen W, Curtiss R
Department of Biology, Washington University, St. Louis, Missouri, 63130, USA.
Microb Pathog. 1999 Mar;26(3):121-30. doi: 10.1006/mpat.1998.0245.
We previously reported that Salmonella typhimurium SR-11 mutants with deletion mutations in the genes encoding adenylate cyclase (cya) and the cAMP receptor protein (crp) are avirulent and protective in mice. Salmonella typhimurium UK-1 is highly virulent for chicks (oral LD50 of 3x10(3) CFU) and mice (oral LD50 of 8.5x10(3) CFU) and is capable of lethal infections in pigs, calves and horses. We postulated that attenuated derivatives of this lethal strain would probably induce a higher level of protective immunity than achieved with attenuated derivatives of less virulent S. typhimurium strains such as SR11. To test this hypothesis, we have constructed S. typhimurium UK-1 Deltacya-12Deltacrp-11 mutant strain chi3985 and its virulence plasmid cured derivative chi4095 to investigate their avirulence and immunogenicity in mice. We found that the mutants are avirulent and able to induce protective immune responses in BALB/c mice. These mutant strains retained wild-type ability to colonize the gut associated lymphoid tissue but reach and persist in spleen and liver at a significantly lower level than the wild-type parent strain. Mice survived oral infection with >1x10(9) CFU of chi3985 (the equivalent to 10(5) 50% lethal doses of wild-type S. typhimurium UK-1) and were fully protected against challenge with 10(5)times the LD50 of the wild-type parent. Immunized mice developed a high level of serum IgG titre to Salmonella LPS and delayed-type hypersensitivity (DTH) response to S. typhimurium outer membrane proteins. Compared to the virulence plasmid-containing strain chi3985, the virulence plasmid cured DeltacyaDeltacrp mutant strain chi4095 was more attenuated and less protective, as some mice immunized with chi4095 died when challenged with the wild-type UK-1 strain. This work demonstrates that S. typhimurium UK-1 Deltacrp Deltacya mutant strain may be a potential live vaccine to induce protective immunity against Salmonella infection or to deliver foreign antigens to the immune system.
我们之前报道过,编码腺苷酸环化酶(cya)和cAMP受体蛋白(crp)的基因发生缺失突变的鼠伤寒沙门氏菌SR-11突变体在小鼠中无致病性且具有保护作用。鼠伤寒沙门氏菌UK-1对雏鸡(口服半数致死量为3×10³CFU)和小鼠(口服半数致死量为8.5×10³CFU)具有高度致病性,并且能够在猪、牛和马中引发致死性感染。我们推测,这种致死菌株的减毒衍生物可能比毒力较低的鼠伤寒沙门氏菌菌株(如SR11)的减毒衍生物诱导更高水平的保护性免疫。为了验证这一假设,我们构建了鼠伤寒沙门氏菌UK-1 Deltacya-12Deltacrp-11突变株chi3985及其毒力质粒缺失衍生物chi4095,以研究它们在小鼠中的无致病性和免疫原性。我们发现这些突变体无致病性,并且能够在BALB/c小鼠中诱导保护性免疫反应。这些突变株保留了在肠道相关淋巴组织中定殖的野生型能力,但在脾脏和肝脏中定殖并持续存在的水平明显低于野生型亲本菌株。小鼠口服感染>1×10⁹CFU的chi3985(相当于野生型鼠伤寒沙门氏菌UK-1的10⁵个半数致死剂量)后存活,并且对野生型亲本半数致死量10⁵倍的攻击具有完全保护作用。免疫小鼠产生了高水平的针对沙门氏菌LPS的血清IgG滴度以及对鼠伤寒沙门氏菌外膜蛋白的迟发型超敏反应(DTH)。与含有毒力质粒的菌株chi3985相比,毒力质粒缺失的DeltacyaDeltacrp突变株chi4095减毒程度更高但保护性更低,因为一些用chi4095免疫的小鼠在受到野生型UK-1菌株攻击时死亡。这项工作表明,鼠伤寒沙门氏菌UK-1 Deltacrp Deltacya突变株可能是一种潜在的活疫苗,可诱导针对沙门氏菌感染的保护性免疫或向免疫系统递送外源抗原。